Neurodegenerative Disease Lab

PUBLICATIONS

papers list
3	Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer’s disease. Sung YM, Lee TH, Yoon HJ, DiBattista AM, Song JM, Sohn YJ, Moffat EI, Turner RS, Jung M, Kim J, Hoe HS. [Experimental Neurology. (2012) ] Abstract
2	FE65 as a link between VLDLR and APP to regulate their trafficking and processing. Dumanis SB, Chamberlain KA, Sohn YJ, Lee YJ, Guenette SY, Suzuki T, Mattews PM, Pak DTS, Rebeck GW, Suh YH, Park HS, Hoe HS. [Mol Neurodegener (2012) ] Abstract
1	MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Kim J, Yoon H, Ramirez CM, Lee SM, Hoe HS, Fernandez-Hernando C, Kim J. [Exp Neurol. (2012) ] Abstract